Clinical Trials Logo

Clinical Trial Summary

This is an RCT among UPHS employees between ages 50-64 comparing no incentive and a loss-framed incentive for completing cancer health risk assessment. Those eligible will receive the phone number for direct colonoscopy scheduling, with the incentive arm receiving an additional unconditional incentive. The primary outcome is completion of screening colonoscopy. Secondary outcomes include scheduling of colonoscopy and completion of risk assessment.


Clinical Trial Description

Colorectal cancer (CRC) is the second leading cause of cancer death in the United States. Despite effective screening and treatment strategies, screening rates remain at 59-65%. UPHS employees have similarly limited rates of CRC screening despite having awareness, access, and insurance coverage. There is a need to identify those who are not up-to-date on screening and eligible for outreach in this population. Financial incentives informed by behavioral economic principles could be used to encourage self-report about screening status and completion of CRC screening. This research utilizes a digital health platform, Way to Health, to evaluate the feasibility of a cancer health risk assessment. This is a single-center RCT among UPHS employees between ages 50-64 that will randomize eligible participants into one of two study arms: (1) no incentive to complete cancer health risk assessment (no incentive) or (2) loss-framed incentive to complete cancer health risk assessment (incentive). Those that are eligible for screening will receive a direct access phone number to schedule colonoscopy, with an additional unconditional incentive for those in incentive arm. The primary outcome is completion of screening colonoscopy, with secondary outcomes of colonoscopy scheduling and completion of risk assessment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03068052
Study type Interventional
Source University of Pennsylvania
Contact
Status Completed
Phase N/A
Start date May 8, 2017
Completion date November 8, 2017

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03446157 - Palbociclib and Cetuximab in Metastatic Colorectal Cancer Phase 2
Recruiting NCT05955196 - Test of CD47-SIRPĪ± Inhibitors on the Immune Microenvironment Colon Cancer
Completed NCT01287130 - AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer Phase 1
Active, not recruiting NCT05179837 - Endoscopic Optical Coherence Tomography for Screening and Diagnosis of Colorectal Precancerous and Malignant Polyps N/A
Completed NCT02929186 - Opt-In Versus Opt-Out for Colorectal Cancer Screening Outreach N/A
Completed NCT02660671 - Behavioral Economic Approaches to Increase Colorectal Cancer Screening N/A
Completed NCT03072095 - Colorectal Cancer Screening in a Community Health Setting N/A